Harte Hanks (HHS) Shares Outstanding (Weighted Average) (2010 - 2026)

Harte Hanks (HHS) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $7.4 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 0.76% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.4 million (up 0.76% YoY) and the FY2025 annual result came in at $7.4 million, up 1.37% from the prior year.
• Shares Outstanding (Weighted Average) was little changed at $7.4 million in Q1 2026 per HHS's latest filing, from $7.4 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $7.4 million in Q1 2023 and bottomed at $7.0 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $7.3 million (2023), against an average of $7.3 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) increased 6.21%; it then declined 2.55% in 2024.
• Tracing HHS's Shares Outstanding (Weighted Average) over 5 years: stood at $7.1 million in 2022, then advanced by 2.94% to $7.3 million in 2023, then declined by 0.23% to $7.3 million in 2024, then gained by 1.37% to $7.4 million in 2025, then rose by 0.31% to $7.4 million in 2026.
• Per Business Quant, the three latest HHS Shares Outstanding (Weighted Average) figures stand at $7.4 million (Q1 2026), $7.4 million (Q4 2025), and $7.4 million (Q3 2025).

Peer Comparison